Spanish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Transdermal Nicotine and Melatonin Patches for Postoperative Pain Relief

Solo los usuarios registrados pueden traducir artículos
Iniciar sesión Registrarse
El enlace se guarda en el portapapeles.
EstadoTerminado
Patrocinadores
Ain Shams University

Palabras clave

Abstracto

Sixty female non-smoker patients, aged 18-50 years and ASA I and II undergoing elective laparoscopic cholecystectomy under general anesthesia were included in this randomized controlled double-blind study. Patients were randomly divided into 3 groups 20 each, C group patients received transdermal placebo patch, TDN group (15 mg/16 h) and TDM group (7 mg/8h). Assessment of postoperative pain, sedation, hemodynamic variables such as HR and MAP, postoperative monitoring of arterial SpO2 and side effects (e.g. nausea, vomiting, pruritis, respiratory depression and hemodynamic instability) were done 30 minutes, 1, 2, 6 and 12 hours postoperatively. Postoperative Patient`s and Surgeons` satisfaction, Intraoperative bleeding and plasma cortisol (µg / dl) 2 hours postoperatively were also assessed.

fechas

Verificado por última vez: 03/31/2016
Primero enviado: 03/31/2016
Inscripción estimada enviada: 04/18/2016
Publicado por primera vez: 04/21/2016
Última actualización enviada: 04/18/2016
Última actualización publicada: 04/21/2016
Fecha de inicio real del estudio: 03/31/2013
Fecha estimada de finalización primaria: 06/30/2015
Fecha estimada de finalización del estudio: 06/30/2015

Condición o enfermedad

Postoperative Pain Relief

Intervención / tratamiento

Drug: C group, (n=20)

Drug: TDN group, (n=20)

Drug: TDM group, (n=20)

Fase

Fase 4

Grupos de brazos

BrazoIntervención / tratamiento
Placebo Comparator: C group, (n=20)
C group (n=20) (placebo group) each patient received transdermal placebo patch, identical placebo patches custom-made by 1-800-Patches (Salt Lake City, UT) placed 2 hours preoperatively for acute postoperative pain after laparoscopic cholecystectomy.
Drug: C group, (n=20)
Postoperative pain was evaluated based on visual analogue scale, first time to ask for rescue analgesia and total pethidine requirements (mg) in 12 hours postoperatively were also recorded.
Active Comparator: TDN group, (n=20)
TDN group (n=20) each patient received transdermal therapeutic system- nicotine (15 mg/16 h),Nicorette® invisi 15mg patch releasing 15mg of nicotine over 16h, produced by Lohmann Therapie-System, Germany placed 2 hours preoperatively for acute postoperative pain after laparoscopic cholecystectomy.
Drug: TDN group, (n=20)
Postoperative pain was evaluated based on visual analogue scale, first time to ask for rescue analgesia and total pethidine requirements (mg) in 12 hours postoperatively were also recorded.
Active Comparator: TDM group, (n=20)
TDM group (n=20) each patient received transdermal therapeutic system- melatonin (7 mg/8h),melatonin sleep patch from Respro Labs ™ containing 7 mg of melatonin placed 2 hours preoperatively for acute postoperative pain after laparoscopic cholecystectomy.
Drug: TDM group, (n=20)
Postoperative pain was evaluated based on visual analogue scale, first time to ask for rescue analgesia and total pethidine requirements (mg) in 12 hours postoperatively were also recorded.

Criterio de elegibilidad

Edades elegibles para estudiar 18 Years A 18 Years
Sexos elegibles para estudiarFemale
Acepta voluntarios saludablessi
Criterios

Inclusion Criteria:

- 60 female patients.

- non-smoker patients.

- aged between 18 and 50 years old.

- ASA physical status I and II.

- 70-90 kg body weight and height 160-180 cm.

- undergoing elective laparoscopic cholecystectomy under general anesthesia.

Exclusion Criteria:

- Patients with impaired kidney or liver functions.

- history of cardiac or central nervous system disease.

- history of smoking.

- history of drug or alcohol abuse.

- history of chronic pain or daily intake of analgesics.

- uncontrolled medical disease (diabetes mellitus and hypertension).

- history of intake of non-steroidal anti-inflammatory drugs or opioids within 24 h before surgery.

- allergy to the used medications.

- coagulation defect.

- local infection at the site of application of transdermal patch.

- patient`s refusal.

- duration of surgery more than 120 minutes.

Salir

Medidas de resultado primarias

1. A mean difference of total analgesic (pethidine) consumption. [[Time Frame: The total pethidine requirements (mg) 12 hours postop]]

Únete a nuestra
página de facebook

La base de datos de hierbas medicinales más completa respaldada por la ciencia

  • Funciona en 55 idiomas
  • Curas a base de hierbas respaldadas por la ciencia
  • Reconocimiento de hierbas por imagen
  • Mapa GPS interactivo: etiquete hierbas en la ubicación (próximamente)
  • Leer publicaciones científicas relacionadas con su búsqueda
  • Buscar hierbas medicinales por sus efectos.
  • Organice sus intereses y manténgase al día con las noticias de investigación, ensayos clínicos y patentes.

Escriba un síntoma o una enfermedad y lea acerca de las hierbas que podrían ayudar, escriba una hierba y vea las enfermedades y los síntomas contra los que se usa.
* Toda la información se basa en investigaciones científicas publicadas.

Google Play badgeApp Store badge